Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HYUNDAI BIOSCIENCE’s research & innovation center has continuously produced globally recognized research results with the commercialization of LDH based on Organic-Inorganic Hybrid technology. Based on the long accumulated research know-how, HYUNDAI BIOSCIENCE is the only company commercialized new DDS (Drug Delivery System) using LDH Platform Technology. Through application of LDH Platform Technology, our research & innova...
HYUNDAI BIOSCIENCE’s research & innovation center has continuously produced globally recognized research results with the commercialization of LDH based on Organic-Inorganic Hybrid technology. Based on the long accumulated research know-how, HYUNDAI BIOSCIENCE is the only company commercialized new DDS (Drug Delivery System) using LDH Platform Technology. Through application of LDH Platform Technology, our research & innovation center has developed a variety of DDS commercialization techniques such as oral, dermal and injection. We hold various patents for these techniques and materials both domestically and internationally.

List your booth number for exhibitions, ask us